Karyopharm Therapeutics Inc (KPTI) is near the middle in its industry group according to InvestorsObserver. KPTI gets an overall rating of 41. That means it scores higher than 41 percent of stocks. Karyopharm Therapeutics Inc gets a 38 rank in the Biotechnology industry. Biotechnology is number 38 out of 148 industries.
KPTI has an Overall Score of 41. Find out what this means to you and get the rest of the rankings on KPTI!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Karyopharm Therapeutics Inc Stock Today?
Karyopharm Therapeutics Inc (KPTI) stock is trading at $3.52 as of 3:49 PM on Monday, Mar 20, a rise of $0.12, or 3.38% from the previous closing price of $3.40. The stock has traded between $3.22 and $3.59 so far today. Volume today is 2,209,169 compared to average volume of 2,385,440.
Click Here to get the full Stock Report for Karyopharm Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
